To the Editor, We read with great interest the systematic review by Fermi et al. [1] regarding the omission of routine level IIB dissection during elective neck dissection (END) in clinically node-negative (cN0) head and neck squamous cell carcinoma (HNSCC). While their pooled estimates offer a valuable baseline, several modern oncological nuances warrant extreme caution before implementing blanket avoidance in surgical practice. Our primary concern is the limited sample size for specific subsites. The cohorts for oropharyngeal (n = 113) and hypopharyngeal cancer (n = 39), in particular, are so small that they underrepresent the true occult metastasis rates in these biologically aggressive subsites. Second, the lack of human papillomavirus (HPV) stratification is a significant blind spot. HPV-positive oropharyngeal SCC exhibits unique nodal dissemination patterns, and the often-encountered bulky level IIA nodes necessitate adjacent level IIB clearance due to direct anatomical contiguity. Pooling these distinct cohorts therefore compromises the generalizability of the findings. Furthermore, their analysis does not fully clarify patterns of contiguous spread. Prospective data from Gallo et al. [2] demonstrated a strong association (p < 0.001) between level IIA and IIB metastases, confirming that level IIB involvement rarely occurs as an isolated skip metastasis. Surgical clearance should thus be guided by the intraoperative or pathological status of level IIA rather than a predetermined omission of level IIB across all cN0 cases. Additionally, while the authors emphasize spinal accessory nerve (SAN) morbidity, sublevel IIB dissection is a highly standardized procedure. Data from the literature and our personal experience suggest that this procedure adds minimal operative time (often < 10 min) when performed by experienced surgeons [3, 4]. Complete omission is also difficult to justify when balanced against modest transient morbidity rates (2%–4%) and the devastating impact of regional recurrence. The clinical utility of the meta-analysis is further limited by high statistical heterogeneity in the oral cavity cohort (I2 = 63.2%) and underreported functional shoulder outcomes (only two of 35 studies provided detailed SAN data). In conclusion, while preserving sublevel IIB is functionally appealing, the current evidence base remains weak for oropharyngeal and hypopharyngeal subsites. Risk-stratified approaches, including sentinel node biopsy, may offer safer alternatives [5]. Robust contemporary prospective trials incorporating modern imaging, HPV status, quality-of-life outcomes, and the unascertained role of adjuvant treatments are urgently needed.
Omission of Level IIB Dissection in cN0 HNSCC : Some Caveats! / Locatello, L.G., Gallo, O.. - In: HEAD & NECK. - ISSN 1043-3074. - ELETTRONICO. - (2026), pp. 0-0. [10.1002/hed.70422]
Omission of Level IIB Dissection in cN0 HNSCC : Some Caveats!
Locatello, Luca Giovanni;Gallo, Oreste
2026
Abstract
To the Editor, We read with great interest the systematic review by Fermi et al. [1] regarding the omission of routine level IIB dissection during elective neck dissection (END) in clinically node-negative (cN0) head and neck squamous cell carcinoma (HNSCC). While their pooled estimates offer a valuable baseline, several modern oncological nuances warrant extreme caution before implementing blanket avoidance in surgical practice. Our primary concern is the limited sample size for specific subsites. The cohorts for oropharyngeal (n = 113) and hypopharyngeal cancer (n = 39), in particular, are so small that they underrepresent the true occult metastasis rates in these biologically aggressive subsites. Second, the lack of human papillomavirus (HPV) stratification is a significant blind spot. HPV-positive oropharyngeal SCC exhibits unique nodal dissemination patterns, and the often-encountered bulky level IIA nodes necessitate adjacent level IIB clearance due to direct anatomical contiguity. Pooling these distinct cohorts therefore compromises the generalizability of the findings. Furthermore, their analysis does not fully clarify patterns of contiguous spread. Prospective data from Gallo et al. [2] demonstrated a strong association (p < 0.001) between level IIA and IIB metastases, confirming that level IIB involvement rarely occurs as an isolated skip metastasis. Surgical clearance should thus be guided by the intraoperative or pathological status of level IIA rather than a predetermined omission of level IIB across all cN0 cases. Additionally, while the authors emphasize spinal accessory nerve (SAN) morbidity, sublevel IIB dissection is a highly standardized procedure. Data from the literature and our personal experience suggest that this procedure adds minimal operative time (often < 10 min) when performed by experienced surgeons [3, 4]. Complete omission is also difficult to justify when balanced against modest transient morbidity rates (2%–4%) and the devastating impact of regional recurrence. The clinical utility of the meta-analysis is further limited by high statistical heterogeneity in the oral cavity cohort (I2 = 63.2%) and underreported functional shoulder outcomes (only two of 35 studies provided detailed SAN data). In conclusion, while preserving sublevel IIB is functionally appealing, the current evidence base remains weak for oropharyngeal and hypopharyngeal subsites. Risk-stratified approaches, including sentinel node biopsy, may offer safer alternatives [5]. Robust contemporary prospective trials incorporating modern imaging, HPV status, quality-of-life outcomes, and the unascertained role of adjuvant treatments are urgently needed.| File | Dimensione | Formato | |
|---|---|---|---|
|
Head Neck - 2026 - Locatello - Omission of Level IIB Dissection in cN0 HNSCC Some Caveats.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
94.5 kB
Formato
Adobe PDF
|
94.5 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



